Delivery Order SPE2DB22D2206-SPE2DB24FFL71
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $27,447.94 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- This is a $1,233.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trokendi XR 25 mg capsules. The award has an ultimate completion date of March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Trokendi XR 100 mg capsules (30-count) with a ceiling value of $3,369.96. This firm fixed-price delivery order, which must be completed by January 23, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The award was not set aside for any specific...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,053.04, is a delivery order for the supply of Trokendi XR 100 mg capsules. The contract has a period of performance through February 24, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,925.48 firm-fixed-price delivery order is for the supply of 4,565,941,399 units of the pharmaceutical product Trokendi XR 50 mg capsules, which are used to treat certain medical conditions. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $6,003.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $22,513.60, is for the delivery of the pharmaceutical product Trokendi XR 200 mg capsules. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trokendi XR 25 mg capsules. The total potential value of this order is $1,206.71, with a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards to provide pharmaceutical products and medical supplies to DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,436.67, is for the delivery of Trokendi XR 100 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFL71Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,076.16 contract is for the delivery of Trokendi XR 25 mg capsules to support military treatment programs and medical facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to the Department of Defense. This specific award was not associated with any set-aside designations. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/5/24 |